Endoplasmic reticulum stress in steroid-induced osteonecrosis: translational bottlenecks and targeted therapeutic

Tianpeng Liu1,2,3,4, Yi Shen1,2,3,4, Wenhao Wang5

  • 1Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Insights

Endoplasmic reticulum stress (ERS) drives steroid-induced osteonecrosis of the femoral head (SONFH) by causing cell death and impairing blood vessel repair. Combinatorial therapies targeting ERS may overcome treatment barriers for this orthopedic disease.

Area of Science:

  • Orthopedics
  • Molecular Biology
  • Pathology

Background:

  • Steroid-induced osteonecrosis of the femoral head (SONFH) is a debilitating orthopedic condition with poorly understood molecular mechanisms.
  • Glucocorticoids are a known cause, but the cellular pathways leading to tissue destruction require further elucidation.
  • Endoplasmic reticulum stress (ERS) is increasingly recognized as a central player in SONFH pathogenesis.

Purpose of the Study:

  • To synthesize current evidence on the role of ERS in SONFH.
  • To explore the signaling paradoxes and translational challenges associated with ERS in SONFH.
  • To propose novel therapeutic strategies for SONFH.

Main Methods:

  • Comprehensive literature review of ERS mechanisms in SONFH.
  • Analysis of molecular pathways including PERK-CHOP, mTOR, and HIF-1α.
  • Evaluation of microenvironmental factors and lipid metabolism interactions.
  • Assessment of translational barriers in animal models.

Main Results:

  • ERS induces osteoblast apoptosis via the PERK-CHOP pathway and inhibits endothelial regeneration by suppressing mTOR signaling.
  • ERS exhibits heterogeneous effects, promoting chondrocyte matrix degradation via HIF-1α stabilization.
  • ERS worsens intraosseous ischemia through a positive feedback loop with lipid metabolism.
  • The 'ischemic island' effect and animal model limitations hinder clinical translation of ERS inhibitors.

Conclusions:

  • ERS is a critical mediator of SONFH pathology through diverse cellular and molecular mechanisms.
  • Combinatorial approaches using ERS modulators and targeted delivery systems are promising for overcoming therapeutic hurdles.
  • Advanced nanocarrier strategies could breach the ischemic barrier, enabling precision joint-preserving therapies for SONFH.

Related Concept Videos

Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...